Intellia Therapeutics, Inc. (NTLA)
12.65
-0.42
(-3.21%)
USD |
NASDAQ |
Oct 12, 15:14
Intellia Therapeutics Free Cash Flow (Quarterly) : -84.92M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -84.92M |
| March 31, 2026 | -117.42M |
| December 31, 2025 | -69.41M |
| September 30, 2025 | -76.93M |
| June 30, 2025 | -99.86M |
| March 31, 2025 | -149.66M |
| December 31, 2024 | -86.18M |
| September 30, 2024 | -86.12M |
| June 30, 2024 | -59.20M |
| March 31, 2024 | -123.17M |
| December 31, 2023 | -94.57M |
| September 30, 2023 | -105.71M |
| June 30, 2023 | -94.62M |
| March 31, 2023 | -113.16M |
| December 31, 2022 | -93.78M |
| September 30, 2022 | -82.76M |
| June 30, 2022 | -89.07M |
| March 31, 2022 | -81.23M |
| December 31, 2021 | -57.52M |
| September 30, 2021 | -69.56M |
| June 30, 2021 | -55.92M |
| Date | Value |
|---|---|
| March 31, 2021 | -54.79M |
| December 31, 2020 | -41.23M |
| September 30, 2020 | -29.26M |
| June 30, 2020 | 56.38M |
| March 31, 2020 | -39.39M |
| December 31, 2019 | -31.23M |
| September 30, 2019 | -27.20M |
| June 30, 2019 | -28.62M |
| March 31, 2019 | -22.99M |
| December 31, 2018 | -10.13M |
| September 30, 2018 | -14.47M |
| June 30, 2018 | -23.40M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -23.70M |
| September 30, 2017 | -19.15M |
| June 30, 2017 | -16.95M |
| March 31, 2017 | -15.56M |
| December 31, 2016 | -17.82M |
| September 30, 2016 | -8.215M |
| June 30, 2016 | 66.40M |
| March 31, 2016 | -10.43M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Twist Bioscience Corp. | -8.648M |
| Beam Therapeutics, Inc. | -68.51M |
| Prime Medicine, Inc. | -41.09M |
| Moderna, Inc. | -563.00M |
| Q32 Bio, Inc. | -3.075M |